Australia markets open in 42 minutes

Allogene Therapeutics, Inc. (ALLO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.88+0.26 (+2.45%)
At close: 04:00PM EDT
10.88 0.00 (0.00%)
After hours: 06:12PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts18181918
Avg. Estimate-0.64-0.71-2.45-2.85
Low estimate-0.91-0.95-2.65-3.36
High estimate-0.53-0.5-2.14-2.13
Year ago EPS-0.57-0.54-1.89-2.45
Revenue estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts14141714
Avg. Estimate10k70k170k3.92M
Low estimateN/AN/AN/AN/A
High estimate90k850k1M46.37M
Year ago sales10k51k38.49M170k
Sales growth (year/est)0.00%37.30%-99.60%2,205.90%
Earnings history29/09/202130/12/202130/03/202229/06/2022
Est. EPS-0.56-0.6-0.58-0.61
Actual EPS-0.57-0.54-0.56-0.52
Difference-0.010.060.020.09
Surprise %-1.80%10.00%3.40%14.80%
EPS trendCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Current estimate-0.64-0.71-2.45-2.85
7 days ago-0.64-0.71-2.45-2.83
30 days ago-0.65-0.72-2.47-2.87
60 days ago-0.69-0.71-2.58-2.87
90 days ago-0.69-0.71-2.58-2.87
EPS revisionsCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1111
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/A111
Growth estimatesALLOIndustrySector(s)S&P 500
Current qtr.-12.30%N/AN/AN/A
Next qtr.-31.50%N/AN/AN/A
Current year-29.60%N/AN/AN/A
Next year-16.30%N/AN/AN/A
Next 5 years (per annum)1.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A